43 studies found for:    Open Studies | "Herpes Zoster"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Herpes Zoster"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Acupuncture in Herpes Zoster Neuralgia (ACUZoster)
Conditions: Herpes Zoster;   Postherpetic Neuralgia;   Pain
Interventions: Device: Sham-laser acupuncture;   Drug: gabapentine;   Procedure: Acupuncture
2 Recruiting Herpes Zoster Vaccine for Bone Marrow Transplant Donors
Condition: Herpes Zoster
Intervention: Biological: Zostavax
3 Recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier
Condition: Herpes Zoster
Intervention: Biological: GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A)
4 Recruiting Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy
Condition: Herpes Zoster
Intervention: Other: Data collection
5 Unknown  Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster
Condition: Herpes Zoster
Interventions: Drug: Foscarnet Sodium;   Drug: Acyclovir
6 Recruiting Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
7 Recruiting Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
8 Recruiting A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
9 Recruiting Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis
Condition: Herpes Zoster Keratitis
Interventions: Drug: gancyclovir gel;   Drug: Hypromellose gel
10 Recruiting Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster
Condition: Herpes Zoster
Interventions: Drug: Famciclovir;   Drug: Aciclovir
11 Recruiting A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
Conditions: Shingles;   Herpes Zoster;   Postherpetic Neuralgia
Interventions: Drug: FV-100;   Drug: valacyclovir
12 Recruiting Enhancing a Sustainable Pharmacy-based Immunization Program in Two States
Conditions: Herpes Zoster;   Pneumococcal Infections
Interventions: Behavioral: Enhanced immunization delivery model;   Other: Immunization update
13 Recruiting Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
Conditions: Liver Disease;   Immunosuppression;   Varicella
Intervention: Biological: Vaccination with VZV vaccine
14 Unknown  Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery
Conditions: Varicella;   Hepatitis A
Interventions: Biological: Varicella Vaccine;   Biological: Hepatitis A Vaccine
15 Unknown  Efficacy of TCA Effect on Varicella Atrophic Scars
Condition: Atrophic Varicella Scar
Intervention: Drug: 70% trichloroacetic acid
16 Recruiting A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.
Condition: Chicken-pox Illness (Varicella Virus Disease)
Interventions: Biological: GSK Biologicals varicella vaccine live, HSA-free (GSK 208133);   Biological: GSK Biologicals varicella vaccine live, (GSK 208133)
17 Recruiting Immune Response to Shingles Vaccination
Condition: Shingles
Intervention: Drug: Zoster Vaccine Live
18 Unknown  The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
Condition: Varicella
Interventions: Biological: HBV-3;   Biological: HBV-6;   Biological: varicella-3;   Biological: varicella-6
19 Recruiting Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine
Condition: Persistence of Varicella Immunity
Intervention: Biological: Varicella vaccine
20 Recruiting Zostavax in Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis;   Varicella Zoster
Intervention: Drug: Zostavax (varicella zoster virus) vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years